Ludvigsen, M., Kamper, P., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B.
, d'Amore, F. A. & Honoré, B. (2015).
Relationship of intratumoural protein expression patterns to age and Epstein-Barr virus status in classical Hodgkin lymphoma.
European Journal of Haematology,
97, 137-149.
https://doi.org/10.1111/ejh.12463
Ludvigsen, M., Madsen, C.
, Kamper, P., Hamilton-Dutoit, S. J., Bendix, K.
, D'Amore, F. A. & Honoré, B. (2015).
Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma.
Blood Cancer Journal,
5, Article e293.
https://doi.org/10.1038/bcj.2015.18
Ludvigsen, M., Pedersen, M. B., Poulsen, T. S.
, Hamilton-Dutoit, S. J., Besenbacher, S., Bendix, K., Møller, M. B.
, D'Amore, F. A. & Honoré, B. (2014).
Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified: Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified.
Blood,
124(21), Article 124.
Ludvigsen, M., Kamper, P., Bendix, K.
, Hamilton Dutoit, S. J., Rabinovich, G. A., Møller, M. B.
, Nyengaard, J. R., D'Amore, F. A. & Honoré, B. (2011).
Translational research identifies prognostic markers including galectin-1 in the tumor microenvironment of cHL predictive for relapsed /refractory disease.
Ludvigsen, M., Kamper, P., Sørensen, B. S., Hamilton Dutoit, S. J., Bendix, K., Møller, M. B.
, Alsner, J., D'Amore, F. A. & Honoré, B. (2013).
Specific degradation pattern of peroxiredoxin-1 correlates with adverse outcome in classical Hodgkin lymphoma patients..
Ludvigsen, M., Vase, M. Ø., Bendix, K.
, Hamilton Dutoit, S. J., Rabinovich, G. A., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N.
, Larsen, C. S. & D'Amore, F. A. (2016).
High Intratumoral Expression of Galectin-1 Correlated with Superior Outcome in HIV-associated DLBCL..
Ludvigsen, M., Vase, M. Ø., Hjortebjerg, R., Petruskevicius, I., Pedersen, C., Pedersen, G.
, Sørensen, B., Bjerre, M., Obel, N.
, Honoré, B., Larsen, C. S. & d'Amore, F. (2016).
Low Serum Galectin-1 Levels Predict Future Lymphoma Development in HIV-Positive Patients.
Blood,
128(22), Article 2945.
Ludvigsen, M., Kamper, P., Hamilton Dutoit, S. J., Bendix, K., Moeller, MB.
, d'Amore, F. A. & Honoré, B. (2015).
Relationship of intratumoral protein expression patterns to age and Epstein-Barr virus status in classical Hodgkin lymphoma. European Journal of Haematology,
95(2), 137-49.
Ludvigsen, M., Bjerregård Pedersen, M., Lystlund Lauridsen, K., Svenstrup Poulsen, T.
, Hamilton-Dutoit, S. J., Besenbacher, S., Bendix, K., Møller, M. B., Nørgaard, P.
, d'Amore, F. & Honoré, B. (2018).
Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
Blood Advances,
2(19), 2533-2542.
https://doi.org/10.1182/bloodadvances.2018019893
Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H., Moyer, M. P.
, Stender, M. T., Thorlacius-Ussing, O.
& Honoré, B. (2020).
Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.
International Journal of Molecular Sciences ,
21(10), Article 3466.
https://doi.org/10.3390/ijms21103466
Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H.
, Stender, M. T., Thorlacius-Ussing, O.
& Honoré, B. (2021).
Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers.
Current issues in molecular biology,
43(2), 1043-1056.
https://doi.org/10.3390/cimb43020074
Ludvigsen, L. U. P., Andersen, A. S.
, Hamilton-Dutoit, S., Jensen-Fangel, S., Bøttger, P.
, Handberg, K. J., Ivarsen, P., d'Amore, F., Bibby, B. M., Albertsen, B. K., Jespersen, B. & Thomsen, M. K. (2023).
A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood.
Journal of Clinical Virology,
167, 105579. Article 105579.
https://doi.org/10.1016/j.jcv.2023.105579
Ludvigsen, M., Campbell, A. J.
, Enemark, M. B., Hybel, T. E., Karjalainen-Lindsberg, M.-L., Beiske, K.
, Bjerre, M., Pedersen, L. M., Holte, H., Leppä, S.
, Jørgensen, J. M. & Honoré, B. (2023).
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.
Blood Cancer Journal,
13(1), Article 161.
https://doi.org/10.1038/s41408-023-00931-6
Luchtel, R. A., Dasari, S., Oishi, N.
, Pedersen, M. B., Hu, G., Rech, K. L., Ketterling, R. P., Sidhu, J., Wang, X., Katoh, R., Dogan, A., Kip, N. S., Cunningham, J. M., Sun, Z., Baheti, S., Porcher, J. C., Said, J. W., Jiang, L.
, Hamilton-Dutoit, S. J. ... Feldman, A. L. (2018).
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.
Blood,
132(13), 1386-1398.
https://doi.org/10.1182/blood-2018-03-838524
Leivonen, S.-K., Icay, K., Jäntti, K., Siren, I., Liu, C., Alkodsi, A., Cervera, A.
, Ludvigsen, M., Hamilton-Dutoit, S. J., d'Amore, F., Karjalainen-Lindsberg, M.-L., Delabie, J., Holte, H., Lehtonen, R., Hautaniemi, S. & Leppä, S. (2017).
MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma.
Blood Cancer Journal,
7(12), 654. Article 654.
https://doi.org/10.1038/s41408-017-0033-8
Leivonen, S. K., Friman, T., Autio, M., Vaittinen, S., Jensen, A. W.
, d’Amore, F., Hamilton-Dutoit, S. J., Holte, H., Beiske, K., Kovanen, P. E., Räty, R. & Leppä, S. (2023).
Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas.
Haematologica,
108(11), 3044-3057.
https://doi.org/10.3324/haematol.2023.282831
Kwong, YL., Kim, SJ., Tse, E., Oh, SJ., Kwak, JY., Eom, HS., Do, YR., Mun, YC., Lee, SR., Shin, HJ., Suh, C., Chuang, SS., Tan, D., Lim, ST., Izutsu, K., Suzuki, R., Relander, T.
, d'Amore, F. A., Schmitz, N. ... Kim, WS. (2018).
Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.
Annals of Oncology,
29(1), 256–263.
https://doi.org/10.1093/annonc/mdx684
Kucuk, C., Jiang, B., Hu, X., Gaulard, P., Zhang, W., Xiao, W., Staudt, LM., Iqbal, J., Cornish, A., Kavak, P., Alkan, C., Gong, Q., Yang, Q., Sun, H.
, D'Amore, F. A., Leppa, S., Liu, W., McKeithan, T. & Chan, WC. (2013).
Frequent activating mutations of JAK-Stat Pathway genes in natural killer cell lymphomas.
Blood.
Kim, S. J., Yoon, D. H., Jaccard, A., Chng, W. J., Lim, S. T., Hong, H., Park, Y., Chang, K. M., Maeda, Y., Ishida, F., Shin, D.-Y., Kim, J. S., Jeong, S. H., Yang, D.-H., Jo, J.-C., Lee, G.-W., Choi, C. W., Lee, W.-S., Chen, T.-Y. ... Kim, W. S. (2016).
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.
Lancet Oncology,
17(3), 389-400.
https://doi.org/10.1016/S1470-2045(15)00533-1
Kim, S. J., Lim, J. Q., Laurensia, Y., Cho, J., Yoon, S. E., Lee, J. Y., Ryu, K. J., Ko, Y. H., Koh, Y., Cho, D., Lim, S. T.
, Beck Enemark, M., D'amore, F., Bjerre, M., Ong, C. K. & Kim, W. S. (2020).
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study.
Blood,
136(24), 2754-2763.
https://doi.org/10.1182/blood.2020007247
Kilpivaara, O., Ristolainen, H.
, Kamper, P., Taskinen, M., Saarinen, S., Leppä, S.
, D'Amore, F. A. & Lauri, A. A. (2014).
Identification of novel germline variants in early-onset familial classical Hodgkin lymphoma with exome sequencing.
Blood,
121(24).
Kharfan-Dabaja, M. A., Kumar, A., Ayala, E., Hamadani, M., Reimer, P., Gisselbrecht, C.
, d'Amore, F., Jantunen, E., Ishida, T., Bazarbachi, A., Foss, F., Advani, R., Fenske, T. S., Lazarus, H. M., Friedberg, J. W., Aljurf, M., Sokol, L., Tobinai, K., Tse, E. ... Savani, B. N. (2017).
Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T-Cell and NK/T-Cell Lymphomas: an International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Biology of Blood and Marrow Transplantation,
23(11), 1826-1838.
https://doi.org/10.1016/j.bbmt.2017.07.027
Kelsen, J., Schwindt, H.
, Dige, A. K., D'Amore, F. A., Pedersen, F. S., Agnholt, J., Christensen, L. A.
, Dahlerup, J. F. & Hvas, C. L. (2011).
Infliximab Induces Clonal Expansion of γδ-T Cells in Crohn’s Disease: A Predictor of Lymphoma Risk? P L o S One,
6(3), e17890.
https://doi.org/10.1371/journal.pone.0017890
Kelsen, J., Schwindt, H.
, Dige, A. K., D'Amore, F. A., Pedersen, F. S., Agnholt, J., Christensen, L. A.
, Dahlerup, J. F. & Hvas, C. L. (2010).
Infliximab drives gamma-delta T cell expansion in Crohn's disease - a predictor of lymphoma risk? Blood,
116(21), 4131.
Kelsen, J., Dige, A., Christensen, M.
, D'Amore, F. & Iversen, L. (2014).
Frequency and clonality of peripheral γδ T cells in psoriasis patients receiving anti-TNF-α therapy.
Clinical and Experimental Immunology,
177(1), 142–148.
https://doi.org/10.1111/cei.12331
Kamper, P., Kjeldsen, E., Clausen, N., Bendix, K.
, Hamilton-Dutoit, S. & d'Amore, F. (2005).
Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings.
British Journal of Haematology,
129(5), 615-7.
https://doi.org/10.1111/j.1365-2141.2005.05499.x
Kamper, P., Bendix, K.
, Hamilton-Dutoit, S., Honoré, B., Nyengaard, J. R. & d'Amore, F. (2011).
Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
Haematologica,
96(2), 269-76.
https://doi.org/10.3324/haematol.2010.031542
Kamper, P., Bendix, K.
, Honoré, B., D'Amore, F. A. & Hamilton-Dutoit, S. J. (2012).
Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma: Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma. Abstract from 54th ASH Annual Meeting and Exposition, Atlanta, GA, United States.
Kamper, P., Bendix, K.
, Hamilton-Dutoit, S. J., Honoré, B. & D'Amore, F. A. (2012).
Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma: Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma.
Blood,
120(21), Article 120.
Jørgensen, J. M., Sørensen, F. B., Bendix, K., Nielsen, J. L., Funder, A. M. D., Karkkainen, M. J., Tainola, T.
, Pedersen, F. S., Sørensen, A. B., Kühle, A. V. D. A. & d'Amore, F. A. (2008).
Correlation between epstein-barr virus (EBV) RNA expression and vascular endothelial growth factor (VEGF) expression in different subtypes of peripheral T-cell lymphomas (PTCL) and prognostic implications. In
ANNALS OF ONCOLOGY (Vol. 19, pp. 113-113)
Jørgensen, J. M., Sørensen, F. B., Bendix, K., Nielsen, J. L., Funder, A., Karkkainen, M. J., Tainola, T.
, Sørensen, A. B., Pedersen, F. S. & D'Amore, F. (2009).
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas.
Leukemia and Lymphoma,
50(10), 1647-1660.
https://doi.org/10.1080/10428190903156729,
https://doi.org/10.1080/10428190903156729
Johnson, P., Federico, M., Fossa, A., O'Doherty, M., Roberts, T., Stevens, L., Smith, P., Kirkwood, A., Anghe, G., Trotman, J., Berkahn, L.
, D'Amore, F. A., Enblad, G., Luminari, S., Viney, Z., Radford, J. & Barrington, S. (2013).
Responses and chemotherapy dose adjustment determined by PET-CT imaging: First results from the international response adapted therapy in advanced hodgkin lymphoma (RATHL) study.
Hematological Oncology,
31, 138.
Johnson, PWM., Federico, M., Kirkwood, AA., Fossa, A., Berkahn, L., Carella, AM.
, D'Amore, F. A., Enblad, G., Franceschetto, A., Fulham, M., Luminari, S., O'Doherty, M., Patrick, P., Roberts, T., Sidra, G., Stevens, L., Smith, P., Trotman, J., Viney, Z. ... Barrington, SF. (2016).
Treatment adaptation guided by interim PET scan in advanced Hodgkin lymphoma.
The New England Journal of Medicine,
374(25), 2419-29.
https://doi.org/10.1056/NEJMoa1510093.
Johnson, P., Federico, M., Kirkwood, A. A., Fossa, A., Berkahn, L., Carella, A.
, d'Amore, F., Enblad, G., Franceschetto, A., Fulham, M. J., Luminari, S., O'Doherty, M. J., Patrick, P., Roberts, T. H., Sidra, G., Stevens, L., Smith, P., Trotman, J., Viney, Z. N. ... Barrington, S. (2016).
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
The New England Journal of Medicine,
374(25), 2419-2429.
https://doi.org/10.1056/NEJMoa1510093
Jepsen, J. R.
, d'Amore, F., Baandrup, U., Clausen, M. R., Gottschalck, E. & Aasted, B. (2009).
Aleutian mink disease virus and humans.
Emerging Infectious Diseases (Print Edition),
15(12), 2040-2.
https://doi.org/10.3201/eid1512.090514